Journal
ACS NANO
Volume 12, Issue 7, Pages 6536-6544Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.8b00553
Keywords
mesenchymal stem cells; red blood cells; biomimetic; nanoparticles; membrane cloaking; liver failure
Categories
Funding
- National Institute of Health [HL123920, HL137093]
- NC State University Chancellor's Faculty Excellence Program
- NC State Chancellor's Innovation Fund
- University of North Carolina General Assembly Research Opportunities Initiative grant
- Scientific and Technological Project of Henan Province, China [152102410063]
- Henan Province Commission of Heath and Family Planning [2015027]
Ask authors/readers for more resources
Acute liver failure is a critical condition characterized by global hepatocyte death and often time needs a liver transplantation. Such treatment is largely limited by donor organ shortage. Stem cell therapy offers a promising option to patients with acute liver failure. Yet, therapeutic efficacy and feasibility are hindered by delivery route and storage instability of live cell products. We fabricated a nanoparticle that carries the beneficial regenerative factors from mesenchymal stem cells and further coated it with the membranes of red blood cells to increase blood stability. Unlike uncoated nanoparticles, these particles promote liver cell proliferation in vitro and have lower internalization by macrophage cells. After intravenous delivery, these artificial stem cell analogs are able to remain in the liver and mitigate carbon tetrachloride induced liver failure in a mouse model, as gauged by histology and liver function test. Our technology provides an innovative and off-the-shelf strategy to treat liver failure.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available